Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

China looks to boost agricultural exports to India: Xi

Published 11/30/2018, 07:24 PM
© Reuters. FILE PHOTO: Chinese President Xi Jinping and Indian Prime Minister Narendra Modi visit the Hubei Provincial Museum in Wuhan

MUMBAI (Reuters) - China was looking to boost agricultural exports to India while increasing imports of rapeseed and soymeal, President Xi Jinping told Indian Prime Minister Narendra Modi on the sidelines of a G20 meeting on Friday.

Xi also indicated greater trade in the pharmaceuticals sector between China and India, foreign secretary Vijay Gokhale, who was traveling with Modi, said.

"On the economic side, President Xi Jinping referred to enhanced imports of rice and sugar from India and spoke of possibility of greater imports of soymeal and rapeseed," he said.

The meeting at the G20 meeting of industrialized nations was the fourth between Xi and Modi this year as the leaders looked to build on a thaw in ties between the two countries after a military standoff on their disputed border last year, officials told Reuters on Thursday.

China's official Xinhua news agency cited Xi as telling Modi that relations were improving.

The two countries should expand bilateral trade and strengthen investment, Xinhua cited Xi as saying, without giving details.

India's commerce ministry and a six-member Chinese delegation signed an agreement on Wednesday allowing Beijing to inspect imports of Indian fish meal and fish oil in an effort to ease market access for exports of various farm products.

China's Ministry of Commerce told Reuters in a faxed statement on Friday that China was happy about the "constantly improving" investment environment in India with hopes to push for the resumption of Chinese dairy, apples and pears exports.

India banned the import of Chinese apples in 2017 after finding pesticides, while China restricted imports of Indian buffalo meat because of concern over foot and mouth disease.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Their bilateral trade reached $89.6 billion in 2017/18 with a deficit of $62.9 billion in China's favor.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.